Definitions

38   In this Part:

"applications (end date)" means the date established under section 1 (3) of Schedule 2 as the date by which a registrant must apply for a grant of access;

"applications (start date)" means the date established under section 1 (2) (b) of Schedule 2 as the date as of which registrant may apply for a grant of access;

"pre-existing user" means a person who was authorized, on the transition date, to access PharmaNet under section 3 or 18 of the Information Management Regulation, B.C. Reg. 74/2015, as those sections read immediately before the transition date;

"registrant on-behalf-of user" means a person who

(a) holds a grant of access as an on-behalf-of user, and

(b) is a member of a class of registrants with respect to whom the applications (start date) has passed;

"transition date" means the date on which this section came into force.

Transition — pre-existing users

39   (1) Despite section 3 [who may access PharmaNet], a pre-existing user may continue to access PharmaNet on and after the transition date, subject to the following:

(a) any suspension of the user's access;

(b) the limits and conditions, if any, to which the user was subject as of the transition date or, if applicable, as varied after that date;

(c) the limits that apply under Schedule 1 as if the user had been issued a grant of access on or after the transition date.

(2) A pre-existing user's authority under this section to access PharmaNet ends on the earliest of the following dates that applies:

(a) the date the user is prohibited from accessing PharmaNet under section 24 (2) (e) [after a hearing];

(b) if the user is eligible to hold a grant of access as a registrant and

(i) applies for a grant of access on or before the applications (end date) that applies to members of the user's class, the date that the minister issues or refuses to issue the grant, or

(ii) does not apply for a grant of access on or before the applications (end date) that applies to members of the user's class, immediately after that date;

(c) if the user is eligible to hold a grant of access as a device provider agent and

(i) applies for a grant of access on or before August 31, 2023, the date that the minister issues or refuses to issue the grant, or

(ii) does not apply for a grant of access on or before August 31, 2023, on September 1, 2023;

(d) if the user is eligible to hold a grant of access only as an on-behalf-of user and

(i) applies for a grant of access on or before the applications (end date) that applies to members of the class to which the user's principal belongs, the date that the minister issues or refuses to issue the grant, or

(ii) does not apply for a grant of access on or before the applications (end date) that applies to members of the class to which the user's principal belongs, immediately after that date.

(3) If a pre-existing user has more than one principal and those principals are registrants who belong to different classes, the applications (end date) for the purposes of subsection (2) (d) is that which applies with respect to the principal belonging to the class that has the latest applications (end date) of all of the classes to which the user's principals belong.

Transition — registrant on-behalf-of users

40   Unless the minister permits otherwise, a registrant on-behalf-of user's grant of access as an on-behalf-of user is deemed to be revoked on the earliest of the following dates that applies:

(a) if the user applies for a grant of access on or before the applications (end date) that applies to members of the user's class, the date that the minister issues or refuses to issue the grant;

(b) if the user does not apply for a grant of access on or before the applications (end date) that applies to members of the user's class, immediately after that date.

Transition — access from locations without PharmaNet access agreement

41   (1) Despite section 11 (3) (b) [limits on grant of access], a person may access PharmaNet from any location from which the person is authorized by the minister to access PharmaNet.

(2) A person's authority under this section to access PharmaNet from any authorized location ends on the earliest of the following dates:

(a) a date specified by the minister for the purposes of this section;

(b) the date on which a PharmaNet access agreement is made that applies to the location from which that person may access PharmaNet;

(c) September 1, 2023.